Cargando…
Differential Neuroprotective Effects of 5′-Deoxy-5′-Methylthioadenosine
BACKGROUND: 5′-deoxy-5′-methylthioadenosine (MTA) is an endogenous compound produced through the metabolism of polyamines. The therapeutic potential of MTA has been assayed mainly in liver diseases and, more recently, in animal models of multiple sclerosis. The aim of this study was to determine the...
Autores principales: | Moreno, Beatriz, Lopez, Iciar, Fernández-Díez, Begoña, Gottlieb, Miroslav, Matute, Carlos, Sánchez-Gómez, María Victoria, Domercq, María, Giralt, Albert, Alberch, Jordi, Collon, Kevin W., Zhang, Helen, Parent, Jack M., Teixido, Meritxell, Giralt, Ernest, Ceña, Valentín, Posadas, Inmaculada, Martínez-Pinilla, Eva, Villoslada, Pablo, Franco, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944389/ https://www.ncbi.nlm.nih.gov/pubmed/24599318 http://dx.doi.org/10.1371/journal.pone.0090671 |
Ejemplares similares
-
Mechanisms of action of Methylthioadenosine: pathways implicated in neuroprotection in models of Multiple Sclerosis and other neurological diseases
por: Moreno, B, et al.
Publicado: (2010) -
The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
por: Jacobs, Benedikt, et al.
Publicado: (2020) -
5'-Methylthioadenosine and Cancer: old molecules, new understanding
por: Li, Yaofeng, et al.
Publicado: (2019) -
Building Cell Selectivity into CPP-Mediated Strategies
por: Martín, Irene, et al.
Publicado: (2010) -
Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies
por: Brito, V, et al.
Publicado: (2013)